SCHEMBL820253

SCHEMBL820253

FC(F)(F)C1(C(F)(F)F)C=CNC(c2ccccn2)=C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.38
LMNA P02545 3/20 0.38
CCR1 P32246 3/20 0.38
CCR5 P51681 3/20 0.38
CCR8 P51685 3/20 0.38
METAP1 P53582 3/20 0.38
CYP1A2 P05177 1/20 0.38
POLB P06746 1/20 0.38
BLM P54132 1/20 0.38
HIF1A Q16665 1/20 0.38
DOHH Q9BU89 1/20 0.38
P4HTM Q9NXG6 1/20 0.38
TP53 P04637 3/20 0.38
HTT P42858 3/20 0.38
TDP1 Q9NUW8 3/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
ALOX15 P16050 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSP90AA1 P07900 2/20 0.38
ALPL P05186 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL811407 0.85 KDM4E (0.38) KDM4ELMNACCR1CCR5CCR8
SCHEMBL15641196 0.76 KDM4E (0.42) KDM4ELMNACCR1CCR5CCR8
SCHEMBL7589588 0.76 KDM4E (0.42) KDM4ELMNACCR1CCR5CCR8
SCHEMBL435395 0.76 KDM4E (0.42) KDM4ELMNACCR1CCR5CCR8
SCHEMBL1311500 0.74 KDM4E (0.39) KDM4ELMNACCR1CCR5CCR8
SCHEMBL6883837 0.74 KDM4E (0.39) KDM4ELMNACCR1CCR5CCR8
SCHEMBL1312502 0.73 KDM4E (0.38) KDM4ELMNACCR1CCR5CCR8
SCHEMBL7054134 0.73 KDM4E (0.38) KDM4ELMNACCR1CCR5CCR8
SCHEMBL21518186 0.73 KDM4E (0.38) KDM4ELMNACCR1CCR5CCR8
SCHEMBL17912484 0.73 KDM4E (0.38) KDM4ELMNACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8598349-B2 Method for manufacturing conjugated aromatic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-12-03 US disclosed
US-20110275859-A1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED 2011-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275859-A1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND C9, H1-10, CYP1A1 KDM4E 724/4885LMNA 1269/4885CCR1 286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.